Hoffmann-La Roche

Swiss healthcare company
Organization Business Q212646

Facts

23 properties

Identity

Instance of
business, biopharmaceutical company, organization[9][10]
Official website
www.roche.com[21]

Status and dates

Inception
October 1, 1896[18]

Location

Headquarters location
Basel[12]
Location of formation
Basel[19]

Industry and activity

Product or material produced
oseltamivir[22]

People

Chief executive officer
Thomas Schinecker (2023–present)[13]
More facts +6
Country of citizenship
Switzerland[1]
Award received
Public Eye People's Award (2010), Public Eye Swiss Award (2010)[5][6]
Different from
Norda Stelo[26]
IPv4 routing prefix
145.245.0.0/16, 151.120.0.0/16[28][29]
Position held by head of the organization
CEO of Hoffmann-La Roche[27]
Social media followers
75k (66k–248k, n=5)[30][31][32][33][34]
🏷️ Also known as
en F. Hoffmann-La Roche en Roche Group en drug manufacturer Roche en Roche Holding en Hoffmann-La Roche en Roche ar هوفمان-لا روش cs Roche Holding cs Roche Group cs Roche de Roche-Gruppe de Die Schweizer Roche de F. Hoffmann-La Roche de Pharmakonzern Roche de Roche de Roche Aktie de Roche-Aktien de Roche Holding es Roche es Roche Holding
🔖 Identifiers · 48
Legal Entity Identifier
5493006QSC6RF6SEU438
VIAF cluster ID
158855466
Library of Congress Authorities ID
n90689949
GND ID
2118013-1
GRID ID
grid.417570.0
ARCHON code
2077
ArchINFORM person/group ID
48684
Comparably company ID
roche
Described at URL
wikirate.org
Show all 48 identifiers +36
EU Participant Identification Code
999601782
EU VAT number
CH118241
FES digital collections entity ID
340744
Facebook username
roche
Freebase ID
/m/02nyk6
French National Assembly Lobbyist ID
2195
Golden ID (archived)
Roche-6E5JG
Google Scholar organization ID
12446533641104548849
HDS ID
041894
IdRef ID
124952801
Instagram username
roche
J9U entity ID
987007590179505171
KISTI ID
K000228619
Kalliope-Verbund (GND) ID
2118013-1
LinkedIn company or organization ID
roche
LittleSis organization ID
44214
Microsoft Academic ID (discontinued)
118019719
Museum-digital person/organization ID
259571
OSM Name Suggestion Index ID
roche-7872f6, roche-c22d3a
Open Funder Registry funder ID
100004337, 100007013
OpenSecrets organization ID
D000042474
PM20 folder ID
co/019150
Ringgold ID
1529
Swiss Enterprise Identification Number
CHE-116.267.986
Topic's main category
Category:Roche
Wellcome Collection concept ID
bc3mz58j
X (Twitter) username
roche (2009–present), Roche (2009–present)
YouTube channel ID
UCH_ZBgtt6-8-VA52pao0SSA (2005–present)
Zhihu topic ID
19935901

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Has these parts 8
Employees / affiliates 5
Owned entities 4
Field of work 3
← Parent organization or unit 3
Industry 2
Instance of 2
Owner of 2
Belongs to 1
Country 1
Country of citizenship 1
Founder 1
Headquarters location 1
Legal form 1
Location of formation 1
Parent organization or unit 1
Product or material produced 1
Topic's main category 1
← Category's main topic 1
← Child organization or unit 1
← Commissioned by 1
← FactGrid item ID 1
← Manufacturer 1
← Partnership with 1
← Winner 1
Press Enter · cited answer in seconds

FAQs

What awards did Hoffmann-La Roche receive?

Honors received include Public Eye People's Award[5] and Public Eye Swiss Award[6].

🛰️ Living Edge · news-derived, source-cited

high ≥ 0.90 · emerging ≥ 0.65 · low below — calibrated against hand-rated truth (single-source .44 · two-source .62 · production-typical .70), so a band is a measurement, not a promise. High is rare by design: it needs both a supported assertion and an evidence sentence. A confirmed or contradicted chip is a Wikidata cross-check; no chip means Wikidata has no value for that property — the ordinary case here, and it says nothing either way. A confirm-only note marks a property whose check can never disagree (Wikidata's border and capital data is not exhaustive), so silence there is a limit of the check, not of the claim.

Industry healthcare emerging0.764 independent sources

evidence “Columvi is part of Roche's broad and industry-leading CD20xCD3 T-cell-engaging bispecific antibody clinical development programme that also includes Lunsumio® (mosunetuzumab), which aims to provide tailored treatment options that suit the diverse needs, preferences, and experiences of people with blood cancers and healthcare systems.” manilatimes.net · read source

acquired 4ort SIM0660 emerging0.703 independent sources

evidence “Under the terms of the agreement, Roche will acquire exclusive worldwide rights to develop, manufacture, and commercialize SIM0660.” rttnews.com · read source

Stock exchange SIX emerging0.703 independent sources

evidence “Basel, 10 September 2026 - Roche (SIX:” finanznachrichten.de · read source

Show 9 low-confidence claims

Published, not hidden — scoring low is not a reason to withhold a sourced claim. A contradicted chip means Wikidata holds a different value; both are shown so you can judge.

Chief executive officer Thomas Schinecker low0.612 independent sources

evidence ““Scientific innovation has always been the foundation of Roche and Genentech’s success, and the United States remains one of our most important innovation hubs,”commented CEO Thomas Schinecker, as quoted in the press release.” swissinfo.ch · read source

Industry pharmaceuticals low0.612 independent sources

evidence “Over more than 50 years of growth, Roche has significantly expanded its presence in Singapore to encompass its pharmaceuticals, diagnostics and manufacturing divisions.” manilatimes.net · read source

Industry uveitis companies low0.612 independent sources

evidence “Uveitis Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key uveitis companies, including Tarsier Pharma, Oculis Pharma, Roche, Eleven Biotherapeutics, Eli Lilly and Company, Eyevensys, Acelyrin, Affibody Medical, Priovant Therapeutics, and others.” prnewswire.com · read source

Industry uveitis low0.612 independent sources

evidence “Uveitis Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key uveitis companies, including Tarsier Pharma, Oculis Pharma, Roche, Eleven Biotherapeutics, Eli Lilly and Company, Eyevensys, Acelyrin, Affibody Medical, Priovant Therapeutics, and others.” prnewswire.com · read source

Industry haematology low0.612 independent sources

evidence “About Roche in haematology” finanznachrichten.de · read source

Industry autoimmune uveitis low0.612 independent sources

evidence “Uveitis Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key uveitis companies, including Tarsier Pharma, Oculis Pharma, Roche, Eleven Biotherapeutics, Eli Lilly and Company, Eyevensys, Acelyrin, Affibody Medical, Priovant Therapeutics, and others.” prnewswire.com · read source

Industry medicines low0.612 independent sources

evidence “About Roche in haematology Roche has been developing medicines for people with malignant and non-malignant blood diseases for more than 25 years;” manilatimes.net · read source

Inception 1896 low0.612 independent sources

evidence “Roche was founded in Basel, Switzerland in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 150 countries around the world.” finanznachrichten.de · read source

Located in the administrative territorial entity Singapore low0.04contradicted2 independent sources

Reported by straitstimes.com straitstimes.com · read source

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [8] ↑ . GRID. Retrieved . wikidata.org.
  2. [1] ↑ . archINFORM. wikidata.org.
  3. [9] ↑ . wikidata.org.
  4. [10] ↑ . wikidata.org.
  5. [2] ↑ . wikidata.org.
  6. [3] ↑ . wikidata.org.
  7. [4] ↑ . roche.com. roche.com. Provenance: wikidata.org.
  8. [11] ↑ . wikidata.org.
  9. [12] ↑ . wikidata.org.
  10. [5] ↑ . wikidata.org.
  11. [6] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . Retrieved . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . 20th Century Press Archives. Retrieved . wikidata.org.
  17. [7] ↑ . handelskammer-d-ch.ch. Retrieved . handelskammer-d-ch.ch. Provenance: wikidata.org.
  18. [18] ↑ . wikidata.org.
  19. [19] ↑ . wikidata.org.
  20. [20] ↑ . wikidata.org.
  21. [21] ↑ . wikidata.org.
  22. [22] ↑ . wikidata.org.
  23. [23] ↑ . wikidata.org.
  24. [24] ↑ . wikidata.org.
  25. [25] ↑ . wikidata.org.
  26. [26] ↑ . wikidata.org.
  27. [27] ↑ . wikidata.org.
  28. [28] ↑ . apps.db.ripe.net. apps.db.ripe.net. Provenance: wikidata.org.
  29. [29] ↑ . apps.db.ripe.net. apps.db.ripe.net. Provenance: wikidata.org.
  30. [30] ↑ . wikidata.org.
  31. [31] ↑ . wikidata.org.
  32. [32] ↑ . wikidata.org.
  33. [33] ↑ . YouTube API. Retrieved . wikidata.org.
  34. [34] ↑ . YouTube API. Retrieved . wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Hoffmann-La Roche. Retrieved November 14, 2026, from https://4ort.xyz/entity/roche
MLA “Hoffmann-La Roche.” 4ort.xyz Knowledge Graph, 4ort.xyz, 14 Nov. 2026, https://4ort.xyz/entity/roche.
BibTeX @misc{4ortxyz_roche_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Hoffmann-La Roche}}, year = {2026}, url = {https://4ort.xyz/entity/roche}, note = {Accessed: 2026-11-14}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Hoffmann-La Roche — https://4ort.xyz/entity/roche (retrieved 2026-11-14)

Canonical URL: https://4ort.xyz/entity/roche · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 4d ago · Dev Jadiya · 2026-11-14 view diff on Wikidata ↗
    "Changed [hi] labels, descriptions or aliases: QuickStatements 3.0 batch #67776"
  2. 14d ago · Eihel · 2026-11-04 view diff on Wikidata ↗
    OSM Name Suggestion Index ID → roche-7872f6, roche-c22d3a
    "Removed claim: OSM Name Suggestion Index ID: roche-7872f6, #temporary_batch_1793752567616"
  3. 12w ago · Trivialist · 2026-08-22 view diff on Wikidata ↗
    HAND ID → E8F5-59C3-5492-BBDE-7A4E
    "Created claim: HAND ID: E8F5-59C3-5492-BBDE-7A4E, batch #269254"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.